Psoriasis: talking points from recent clinical trials

被引：0
作者：
Chiricozzi, Andrea [1 ,2 ,5 ]
Bellinato, Francesco [3 ]
Romita, Paolo [4 ]
Gisondi, Paolo [3 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Med & Chirurg, UOC Dermatol, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dipartimento Med & Chirurg Traslaz, Dermatol, Rome, Italy
[3] Univ Verona, Dept Med, Sect Dermatol & Venereol, Verona, Italy
[4] Univ Bari, Dept Biomed Sci & Human Oncol, Sect Dermatol, Bari, Italy
[5] Fdn Policlin Univ A Gemelli, Dipartimento Sci Med & Chirurg, UOC Dermatol, IRCCS, Largo Agostino Gemelli 8, I-00168 Rome, Italy
来源：
EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2022年 / 31卷 / 12期
关键词：
EFFICACY; PLACEBO; SAFETY; CREAM;
D O I：
10.1080/13543784.2022.2160314
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1265 / 1267
页数：3
相关论文
共 15 条
  • [1] [Anonymous], 2021, GLOBENEWSWIRE
  • [2] EFFICACY AND SAFETY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 (TYK2) INHIBITOR, COMPARED WITH PLACEBO AND APREMILAST IN MODERATE TO SEVERE PLAQUE PSORIASIS: RESULTS FROM THE PHASE 3 POETYK PSO-1 STUDY
    Armstrong, A.
    Gooderham, M.
    Warren, R. B.
    Papp, K.
    Strober, B.
    Thaci, D.
    Colston, E.
    Throup, J.
    Kundu, S.
    Banerjee, S.
    Blauvelt, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 795 - 796
  • [3] Trial of Spesolimab for Generalized Pustular Psoriasis
    Bachelez, H.
    Choon, S-E
    Marrakchi, S.
    Burden, A. D.
    Tsai, T-F
    Morita, A.
    Navarini, A. A.
    Zheng, M.
    Xu, J.
    Turki, H.
    Anadkat, M. J.
    Rajeswari, S.
    Hua, H.
    Vulcu, S. D.
    Hall, D.
    Tetzlaff, K.
    Thoma, C.
    Lebwohl, M. G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (26) : 2431 - 2440
  • [4] Concomitant atopic dermatitis and psoriasis - a retrospective review
    Barry, Kelly
    Zancanaro, Pedro
    Casseres, Rachel
    Abdat, Rana
    Dumont, Nicole
    Rosmarin, David
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (07) : 716 - 720
  • [5] Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial
    Bissonnette, R.
    Poulin, Y.
    Zhou, Y.
    Tan, J.
    Hong, H. C.
    Webster, J.
    Ip, W.
    Tang, L.
    Lyle, M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (04) : 853 - 860
  • [6] Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature
    Caldarola, G.
    Pirro, F.
    Di Stefani, A.
    Talamonti, M.
    Galluzzo, M.
    D'Adamio, S.
    Magnano, M.
    Bernardini, N.
    Malagoli, P.
    Bardazzi, F.
    Potenza, C.
    Bianchi, L.
    Peris, K.
    De Simone, C.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (06) : 665 - 672
  • [7] Pustular Psoriasis: From Pathophysiology to Treatment
    Genovese, Giovanni
    Moltrasio, Chiara
    Cassano, Nicoletta
    Maronese, Carlo Alberto
    Vena, Gino Antonio
    Marzano, Angelo Valerio
    [J]. BIOMEDICINES, 2021, 9 (12)
  • [8] Gudjonsson JE., 2022, 2022 AM ACAD DERMATO
  • [9] Lebwohl M., 2021, EADV 30 C
  • [10] Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis
    Lebwohl, Mark G.
    Stein Gold, Linda
    Strober, Bruce
    Papp, Kim A.
    Armstrong, April W.
    Bagel, Jerry
    Kircik, Leon
    Ehst, Benjamin
    Hong, H. Chih-ho
    Soung, Jennifer
    Fromowitz, Jeff
    Guenthner, Scott
    Piscitelli, Stephen C.
    Rubenstein, David S.
    Brown, Philip M.
    Tallman, Anna M.
    Bissonnette, Robert
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24) : 2219 - 2229
12